Cannabis Stocks Jump Again as Trump Considers Drug Reclassification

TigerAug 12, 2025 8:06 AM

View all comments（0）



Shares of cannabis-linked companies jumped again in premarket trading on Tuesday after a surge on Monday, as US President Donald Trump said he was considering reclassifying marijuana as a less dangerous drug — giving the sector a much needed boost.

Tilray rose 13%; Canopy Growth rose 9%; SNDL rose 3%.

The Wall Street Journal first reported on Friday that Trump spoke on cannabis reclassification during a fundraising event, citing people familiar with the matter. A new scheduling from the administration could also reignite hope for a broader federal legislation push that is key to unlocking value in the sector.

Cannabis is currently labeled as a Schedule 1 drug — putting it into a category that also includes substances like heroin and LSD. Former Florida Republican representative Matt Gaetz said in a March op-ed that the Trump administration would bring “meaningful change” in reclassifying cannabis to a Schedule III drug, which puts it on the same level as anabolic steroids and the medication Adderall.

“Over the long-term, a rescheduling of cannabis would likely lift the entire sector by bolstering research, reducing stigma, improving access to capital, and opening up a large addressable market,” TD Cowen analyst Derek Lessard wrote in a Monday note.

He rates Canadian cannabis producer Aurora Cannabis a buy, but reminded investors the company has no known plans to enter the US market. Even if the US approved a rescheduling of marijuana’s status, it wouldn’t likely have near-term effects on companies without US operations, he warned.

Rescheduling is also a separate issue than federal legislation. The US operates as a state patchwork system as far as legalization goes and progress on legalizing marijuana on a federal level has been slow. The sector trades well below its 2021 heyday, when rates were lower and investor enthusiasm was at its peak.

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Comments (0)

Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.

Commenting Guidelines

Recommended Articles

Meta Connect 2026 New Product Roundup: Muse Integrated Into AI Glasses, Can It Drive Meta Revenue Growth?

TradingKey - At the Connect 2026 conference held from September 23 to 24, Meta (META) unveiled the Ray-Ban Meta Audio, third-generation Ray-Ban Meta, and Meta VR Glasses, while upgrading the Meta Ray-Ban Display. The company also announced the integration of its personal AI agent, Muse, into its AI glasses, expanding its product scope from mobile phones and social apps to wearable devices.

Today’s Market Recap: 10-Year Treasury Yield Hits Highest Level Since 2007, Major U.S. Indexes Fall, SpaceX Drops Over 4%

TradingKey — Rising Treasury yields and oil prices weighed on U.S. equities, sending all three major indexes lower. On September 23, the 10-year Treasury yield climbed to its highest level since July 2007, while rebounding crude prices intensified concerns over inflation and interest rates. Technolo

Japan Stocks Open Higher After Three-Day Holiday, SoftBank Rises Over 6%, Kioxia Up Nearly 4%; South Korean Markets Closed

TradingKey - On September 24, Japanese stock markets resumed trading after a three-day holiday, with the Nikkei 225 Index (JPN225) opening 0.6% higher and later extending gains to 1.25% to reach 65,828.43 points. Meanwhile, South Korean stock markets were closed for a holiday.

【US Pre-Market】Nasdaq Leads Losses in Three Major Stock Index Futures, IONQ Surges Over 11%, RGTI Rises Over 5% as Market Focuses on US-China Summit

TradingKey - On Wednesday (September 23) Eastern Time, futures tied to the three major U.S. stock indexes edged up in pre-market trading. Diplomatic mediation in the Middle East and the restoration of a key Saudi oil pipeline kept international oil prices below $100 per barrel, temporarily easing energy inflation concerns. Meanwhile, investors are awaiting the summit between Chinese and U.S. leaders and the preliminary U.S. September PMI data, while a strengthening U.S. dollar and the risk of further Federal Reserve rate hikes continue to cap market gains.

The Week Ahead: US-China Summit in Washington, Costco Earnings and Fed Rate Path in Focus

TradingKey - During the week of September 21 to 25, Eastern Time, the US stock market will focus on the meeting between Chinese and US leaders, the Federal Reserve's policy outlook, and economic data such as US new home sales and durable goods orders.

Featured Tools